Ribotype 027 is Associated with Increased Lactoferrin and Toxin in Patients with Clinically Defined C. difficile Disease
Evaluation of Fecal Lactoferrin, CRP and Clinical Activity Indices for Assessing the Presence of Intestinal Inflammation in IBD and IBS Patients Classified by Ileocolonoscopy
Comparison of CRP, Clinical Activity Indices and Fecal Lactoferrin with Disease Status in Ileocolonoscopy of Patients with IBD and IBS
A Comparison Among Four Neutrophil-Derived Proteins in Feces as Indicator of Disease Activity in Ulcerative Colitis
Serial Fecal Lactoferrin Measurements are Useful in the Interval Assessment of Patients with Active and Inactive Inflammatory Bowel Disease
Evaluation of Fecal and Serum Anti-Saccharomyces cerevisiae Antibodies (ASCA) as an Aid in the Diagnosis of Crohn’s Disease
Fecal Lactoferrin: Sensitive Marker for Monitoring Pediatric Patients with Inflammatory Bowel Disease (IBD)
Clinical Evaluation of the IBD-CHEK® Test for Detecting Elevated Fecal Lactoferrin as an Indicator of Intestinal Inflammation in Pediatric Patients
Fecal lactoferrin in newborns, infants and toddlers- Evaluation in asymptomatic children and patients with functional disorders
Fecal ASCA Measurements in the Assessment of Pediatric Patients with Crohn’s Disease (CD) or Suspected Inflammatory Bowel Disease (IBD)
The Detection of Lactoferrin, ASCA and ANCA in Feces is useful for Assessing Pediatric IBD Patients
Measurement of Anti-Saccharomyces cerevisiae Antibodies in Human Feces as an Indicator of Crohn’s Disease
Evaluation of Fecal Biomarkers for Monitoring Antibiotic Treatment of a Patient Infected with Clostridium difficile
Comparison of CRP, Clinical Activity Indices and Fecal Lactoferrin with Disease Status in Ileocolonoscopy of Patients with IBD and IBS
Evaluation of CRP, Fecal Lactoferrin and Clinical Activity Indices for Assessing the Presence of Intestinal Inflammation in IBD and IBS Patients
Lactoferrin as a Predictor of Disease Severity for Clostridium difficile Disease
Tables for Lactoferrin IBD Mucosal Healing
Fecal Lactoferrin in Children with Gastrointestinal Symptoms
Fecal Lactoferrin as an Indicator of Intestinal Inflammation in Patients with Antibiotic-Associated Diarrhea
Fecal Lactoferrin, Calprotectin, PMN-Elastase, CRP and White Blood Count as Indicators for Mucosal Healing and Clinical Course In Ulcerative Colitis: A Prospective 12-Month Monitoring Study
Efficacy of Faecal Lactoferrin in IBS & IBD: A Comparative Study
Evaluation of the LEUKO EZ VUE® for Measuring Fecal Lactoferrin as a Marker of Intestinal Inflammation
Fecal Lactoferrin, Calprotectin, PMN-Elastase, CRP and White Blood Count as Indicators for Mucosal Healing and Clinical Course in Ulcerative Colitis: A Prospective 12-Month Monitoring Study
Feasibility and Utility for Long-Term Monitoring of Fecal Lactoferrin in Patients With Ulcerative Colitis
Fecal Lactoferrin: Reliable Inflammatory Marker in Pediatric IBD
Hospitalized Patients with Ribotype 027 Clostridium difficile Infection and Stool Cytotoxicity Have More Severe Disease with an Increased Risk of Death
Fecal ASCA Measurements in the Assessment of Pediatric Patients with Crohn’s Disease (CD) or Suspected Inflammatory Bowel Disease (IBD)